RE: RE: RE: From all sides Chief:
The solution to your valid concerns about GW is a lot more straightforward than some would have you believe. Call a meeting 60 days out, a full 90 days prior to the AGM.
That gives Bioniche an opportunity to ink a Uro deal and perhaps an AH deal. At the very least they can elaborate on whatever AH deal it is that they are working on. It also gives them time to lay out their business case. They are the incumbent, I would think that they would have a much easier time accessing their own information.
GW hasn't been as forthcoming as some would like, but they have presented their BOD in its entirety and they have been very clear that they cannot release their own plan for Bioncihe through a proxy circular until a special meeting is called. Is this 100% factual, and are there no measures to circumvent this restriction? I don't know, but they are adamant that this is the procedure.
By claiming that the early announcement of the AGM nullifies any requirement for a special meeting is "cheesy", for lack of a better word, and adds to the bad tatse in people's mouths.
One thing I am confident of is that had GW never shown up, and Bioniche unilaterally decided to announce 30 "approaches" for Urocidin and 3 written offers for AH, we'd be trading between 21 and 22 cents. Whether the "market" for Bioniche is real or not, they seem to have nothing left in the tank that will interest anybody until an order, or Urocidin deal or Animal Health sale is signed.
This is a loaded-pipeline spec stock with absolutely no speculation whatsoever. They are hard to find.